Previous 10 | Next 10 |
CONMED press release ( NYSE: CNMD ): Q4 Non-GAAP EPS of $0.42 misses by $0.48 . Revenue of $250.9M (-8.4% Y/Y) misses by $51.58M . 2023 Outlook The Company expects full-year 2023 reported revenue between $1.170 billion and $1.220 billion vs $1.21B consensus, which ...
CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2022. Fourth Quarter 2022 Highlights Fourth quarter 2022 sales significantly impacted by the implementation of new warehouse management software. Sales of ...
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2022 after the market close on Thursday, February 2, 2023. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To partic...
Summary INMD provides a prime opportunity for investors to benefit from the growing demand for non-surgical cosmetic procedures that rely on energy-based devices. INMD manufactures and sells energy based devices used by physicians in these procedures and has between 2019 and 2022 seen a...
Summary CONMED Corporation had a reasonable growth quarter with upsides in key markets. Orthopedics is certainly an exciting growth area and offers leverage with each additional gain in market share. We'd like more time to assess any changes before pulling the trigger on CONMED Corp...
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 34 th Annual Piper Sander Health...
Conmed ( NYSE: CNMD ) withdrew its previously-issued FY22 financial outlook because of a temporary disruption resulting from the implementation of new warehouse management software. The company had said in its Q3 results that it was narrowing its revenue guidance...
CONMED Corporation (NYSE: CNMD) today announced that due to a temporary disruption resulting from the implementation of new warehouse management software, the Company is withdrawing its previously issued full-year 2022 financial outlook. In recent weeks, the Company began implementi...
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Stifel 2022 Healthcare Conference at...
CONMED Corporation (CNMD) Q3 2022 Earnings Conference Call October 26, 2022 04:30 p.m. ET Company Representatives Curt Hartman - Chair of the Board, President, Chief Executive Officer Todd Garner - Executive Vice President, Chief Financial Officer Conference Ca...
News, Short Squeeze, Breakout and More Instantly...
Conmed Corp. - Ordinary Shares Company Name:
CNMD Stock Symbol:
NASDAQ Market:
Conmed Corp. - Ordinary Shares Website:
2024-07-18 18:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CONMED Corporation (NYSE: CNMD) today announced it will report financial results for the second quarter of 2024 after the market close on Wednesday, July 31, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participat...
2024-07-08 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...